Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation
AJ Jääskeläinen, View ORCID ProfileS Kuivanen, View ORCID ProfileE Kekäläinen, MJ Ahava, R Loginov, H Kallio-Kokko, View ORCID ProfileO Vapalahti, View ORCID ProfileH Jarva, View ORCID ProfileS Kurkela, M Lappalainen
doi: https://doi.org/10.1101/2020.05.18.20101618
AJ Jääskeläinen
1HUS Diagnostic Center, HUSLAB, Clinical Microbiology, University of Helsinki and Helsinki University Hospital, Finland
S Kuivanen
2Department of Virology, University of Helsinki, Helsinki, Finland
E Kekäläinen
1HUS Diagnostic Center, HUSLAB, Clinical Microbiology, University of Helsinki and Helsinki University Hospital, Finland
3Translational Immunology Research Program and Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland
MJ Ahava
1HUS Diagnostic Center, HUSLAB, Clinical Microbiology, University of Helsinki and Helsinki University Hospital, Finland
R Loginov
1HUS Diagnostic Center, HUSLAB, Clinical Microbiology, University of Helsinki and Helsinki University Hospital, Finland
H Kallio-Kokko
1HUS Diagnostic Center, HUSLAB, Clinical Microbiology, University of Helsinki and Helsinki University Hospital, Finland
O Vapalahti
1HUS Diagnostic Center, HUSLAB, Clinical Microbiology, University of Helsinki and Helsinki University Hospital, Finland
2Department of Virology, University of Helsinki, Helsinki, Finland
4Depts of Virology and Veterinary Biosciences, University of Helsinki, Helsinki, Finland
H Jarva
1HUS Diagnostic Center, HUSLAB, Clinical Microbiology, University of Helsinki and Helsinki University Hospital, Finland
3Translational Immunology Research Program and Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland
S Kurkela
1HUS Diagnostic Center, HUSLAB, Clinical Microbiology, University of Helsinki and Helsinki University Hospital, Finland
M Lappalainen
1HUS Diagnostic Center, HUSLAB, Clinical Microbiology, University of Helsinki and Helsinki University Hospital, Finland
Article usage
Posted May 22, 2020.
Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation
AJ Jääskeläinen, S Kuivanen, E Kekäläinen, MJ Ahava, R Loginov, H Kallio-Kokko, O Vapalahti, H Jarva, S Kurkela, M Lappalainen
medRxiv 2020.05.18.20101618; doi: https://doi.org/10.1101/2020.05.18.20101618
Subject Area
Subject Areas
- Addiction Medicine (369)
- Allergy and Immunology (689)
- Anesthesia (184)
- Cardiovascular Medicine (2748)
- Dermatology (235)
- Emergency Medicine (414)
- Epidemiology (12398)
- Forensic Medicine (10)
- Gastroenterology (784)
- Genetic and Genomic Medicine (4259)
- Geriatric Medicine (396)
- Health Economics (699)
- Health Informatics (2756)
- Health Policy (1018)
- Hematology (369)
- HIV/AIDS (879)
- Medical Education (404)
- Medical Ethics (112)
- Nephrology (453)
- Neurology (4036)
- Nursing (216)
- Nutrition (598)
- Oncology (2126)
- Ophthalmology (604)
- Orthopedics (251)
- Otolaryngology (312)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (478)
- Pediatrics (1148)
- Primary Care Research (468)
- Public and Global Health (6652)
- Radiology and Imaging (1446)
- Respiratory Medicine (886)
- Rheumatology (421)
- Sports Medicine (353)
- Surgery (464)
- Toxicology (57)
- Transplantation (192)
- Urology (171)